FROM Erin Fox
Can politics cure the high cost of drugs? EpiPens are the poster child for vast increases in the price of familiar medications. Many people carry them for emergency treatment of allergic reactions that can be life threatening. So, when the Mylan Company raised the price of two EpiPens from $100 $614 it made big news. Turns out, it's the tip of the iceberg. Drug prices are on the rise and desperately ill people are often those hit by bills they never expected. Other countries have established price controls for life-or-death medications, but America's system is so complex it defies understanding. Drug and insurance companies, hospitals and doctors engage in secret negotiations, while various middlemen get cuts of the action. And, who's paying for those expensive ads on TV? Patients. Are the presidential campaigns offering any realistic solutions?
The US gets deeper into Middle East wars. What's the endgame? President Trump welcomed Egypt's President Abdul Fattah al-Sisi to the White House today… just one of the changes in America's approach to the Middle East since Barack Obama left office. We hear about that and the escalation of warfare as well as civilian casualties.
Trump's ethical conflicts pile up as transparency diminishes President Trump's refusal to reveal his income tax returns is just one example of a lack of transparency that could be hiding conflicts of interest. Other conflicts are already obvious from his appointments. And he's being sued for using his job to increase his profits.
Will the march for science politicize objective research? Protesters are gathering all over the country for tomorrow's Earth Day March for Science. Since President Trump has proposed massive cuts in basic scientific research, will the movement be perceived as partisan politics — whether scientists themselves like it or not?